Xoma Royalty Corp (XOMA)

Jun 18, 2025

XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewswire

Jun 18, 2025

Jun 18, 2025

XOMA Preferred Stock Pays High-Yield Quarterly Dividend: 8.625% Series A, 8.375% Series B - Stock Titan

Jun 18, 2025

Jun 16, 2025

Bank of America Corp DE Acquires 2,009 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World

Jun 16, 2025

Jun 08, 2025

XOMA Co. (NASDAQ:XOMA) Shares Sold by Squarepoint Ops LLC - Defense World

Jun 08, 2025

Jun 06, 2025

Nuveen Asset Management LLC Increases Stock Position in XOMA Co. (NASDAQ:XOMA) - Defense World

Jun 06, 2025

Jun 05, 2025

XOMA Co. (NASDAQ:XOMA) Shares Sold by BNP Paribas Financial Markets - Defense World

Jun 05, 2025

Jun 02, 2025

BioInvent secured up to $30 million from XOMA Royalty - Biostock

Jun 02, 2025

Jun 01, 2025

Wall Street Zen Upgrades XOMA (NASDAQ:XOMA) to Buy - Defense World

Jun 01, 2025

May 31, 2025

HC Wainwright Issues Positive Outlook for XOMA Earnings - Defense World

May 31, 2025

May 29, 2025

XOMA Co. (NASDAQ:XOMAO) Short Interest Update - Defense World

May 29, 2025

May 29, 2025

XOMA Co. (NASDAQ:XOMAP) Short Interest Update - Defense World

May 29, 2025

May 29, 2025

XOMA’s (XOMA) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

May 29, 2025

May 28, 2025

XOMA Royalty purchases mezagitamab royalty rights from BioInvent International for $30M - MSN

May 28, 2025

May 28, 2025

XOMA stock holds Buy rating, $104 target from H.C. Wainwright - Investing.com

May 28, 2025

May 28, 2025

XOMA stock holds Buy rating, $104 target from H.C. Wainwright By Investing.com - Investing.com South Africa

May 28, 2025

May 28, 2025

XOMA Royalty Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

May 28, 2025

May 28, 2025

XOMA Stock: HC Wainwright & Co. Reiterates Buy Rating with $104 - GuruFocus

May 28, 2025

May 27, 2025

XOMA Purchases Future Mezagitamab Royalty Interests from BioInve - GuruFocus

May 27, 2025

May 27, 2025

XOMA Royalty (XOMA) Acquires Mezagitamab Interests from BioInvent - GuruFocus

May 27, 2025

May 27, 2025

XOMA Royalty (XOMA) Acquires Mezagitamab Interests from BioInven - GuruFocus

May 27, 2025

May 27, 2025

XOMA Royalty Purchases Mezagitamab Royalty and Milestone - GlobeNewswire

May 27, 2025

May 27, 2025

XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million - Yahoo Finance

May 27, 2025

May 25, 2025

Northern Trust Corp Has $2.40 Million Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World

May 25, 2025

May 23, 2025

XOMA (NASDAQ:XOMAO) Stock Price Up 0.1% – Still a Buy? - Defense World

May 23, 2025

May 22, 2025

XOMA (NASDAQ:XOMAP) Trading Up 1.5% – Still a Buy? - Defense World

May 22, 2025

May 20, 2025

Major Shareholder Sells Massive Chunk of Xoma Stock! - TipRanks

May 20, 2025

May 19, 2025

Leerink Partnrs Analysts Boost Earnings Estimates for XOMA - Defense World

May 19, 2025

May 18, 2025

FY2026 Earnings Estimate for XOMA Issued By Leerink Partnrs - Defense World

May 18, 2025

May 16, 2025

Results: XOMA Royalty Corporation Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance

May 16, 2025

May 15, 2025

XOMA Royalty First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 15, 2025

May 14, 2025

XOMA Royalty Reports Strong Q1 2025 Results - TipRanks

May 14, 2025

May 14, 2025

XOMA Royalty Corp Q1 2025 Earnings: EPS of $0.24, Revenue Surges to $15.9 Million, Exceeding Estimates - GuruFocus

May 14, 2025

May 13, 2025

XOMA (XOMA) Surpasses Q1 Revenue Expectations with Strong Pipeli - GuruFocus

May 13, 2025

May 13, 2025

XOMA Royalty (XOMA) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance

May 13, 2025

May 13, 2025

XOMA Royalty Corporation Q1 2025 Financial Results - TradingView

May 13, 2025

May 13, 2025

XOMA Royalty Corp SEC 10-Q Report - TradingView

May 13, 2025

May 13, 2025

XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements - The Manila Times

May 13, 2025

May 12, 2025

Wells Fargo & Company MN Grows Stock Holdings in XOMA Co. (NASDAQ:XOMA) - Defense World

May 12, 2025

May 11, 2025

Barclays PLC Acquires 1,528 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World

May 11, 2025

May 07, 2025

XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference - GlobeNewswire

May 07, 2025

May 05, 2025

XOMA Royalty Corp expected to post a loss of 30 cents a shareEarnings Preview - TradingView

May 05, 2025

May 05, 2025

Renaissance Technologies LLC Buys 7,619 Shares of XOMA Co. (NASDAQ:XOMA) - Defense World

May 05, 2025

May 03, 2025

JPMorgan Chase & Co. Raises Stake in XOMA Co. (NASDAQ:XOMA) - Defense World

May 03, 2025

May 01, 2025

XOMA Co. (NASDAQ:XOMAO) Sees Significant Increase in Short Interest - Defense World

May 01, 2025

Apr 27, 2025

XOMA Co. (NASDAQ:XOMA) Shares Sold by Geode Capital Management LLC - Defense World

Apr 27, 2025

Apr 21, 2025

Short Interest in XOMA Co. (NASDAQ:XOMAP) Drops By 15.9% - Defense World

Apr 21, 2025

Apr 19, 2025

Benchmark Begins Coverage on XOMA (NASDAQ:XOMA) - Defense World

Apr 19, 2025

Apr 17, 2025

Benchmark Initiates Coverage of XOMA Royalty CorporationPreferred Stock (XOMAP) with Buy Recommendation - Nasdaq

Apr 17, 2025

Apr 17, 2025

Benchmark Initiates Coverage of XOMA Royalty (XOMA) with Buy Recommendation - Nasdaq

Apr 17, 2025

Apr 17, 2025

XOMA Co. (NASDAQ:XOMAO) Sees Large Decrease in Short Interest - Defense World

Apr 17, 2025

Apr 15, 2025

Third Harmonic's shutdown, Coherus and Xoma drug sales connectedBizwomen - The Business Journals

Apr 15, 2025

Apr 15, 2025

Big moves by small biotechs signal potential shift for investorsSan Francisco Business Times - The Business Journals

Apr 15, 2025